Project_ID;Project_Title;Funder;Co_funders;Programme_Type;Project_Status;Programme;Programme_Stream;Award_Amount;Start_Date;End_Date;Description;Objectives;Organisation_Type;Contracted_Organisation
GB-GOV-10-AMR_B;Antimicrobial Resistance Cross-Council Initiative: Behaviour Within and Beyond the Healthcare Setting;NIHR (ODA);Economic and Social Research Council;Research;active;Antimicrobial Resistance Cross-Council Initiative: Behaviour Within and Beyond the Healthcare Setting;Commissioned;£3,500,000.00;2017-06-26;31/03/2021;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). This programme is administered by the UK Economic and Social Research Council (ESRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to ESRC, which makes onwards disbursements to awardees. This research call addresses theme four of the cross-Research Council initiative on antimicrobial resistance (AMR): 'Behaviour within and beyond the healthcare setting', and focusses on understanding how the behaviour of public, professionals and organisations impacts on AMR. The Official Development Assistance (ODA)-funded component of this scheme is concerned with focussing high quality research on addressing an issue of global importance and will primarily and directly benefit people in low- and middle-income countries.;"The call aims to expand understanding of how behaviour impacts on antimicrobial resistance (AMR): 1) how it can enhance or control the spread of AMR; 2) how it is affected by social, psychological and organisational context, cultures and history; and 3) how it can be influenced to create different future scenarios.";Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-AMR_GC;Antimicrobial Resistance in a Global Context;NIHR (ODA);Medical Research Council;Research;closed;Antimicrobial Resistance in a Global Context;Commissioned;£6,404,707.00;2017-11-24;31/03/2022;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. This research call supports investments in interdisciplinary and focussed research at international levels to identify the burden and primary drivers of antimicrobial resistance (AMR) and specifically antibacterial resistance in low- and middle-income countries.;1) Draw together UK groups with researchers and policy makers in partner low and middle income countries. 2) Support the use of a range of research approaches, from clinical and microbiological to geography, modelling and social sciences, in order to identify, prioritise and understand the specific problem of antibacterial resistance (ABR) across different communities and environments. 3) Help build capacity in this area of research in partner countries.;Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-GFGP;Good Financial Grants Practice;NIHR (ODA);Not Applicable;Research;active;Good Financial Grants Practice;Commissioned;£500,000.00;2017-12-18;30/11/2018;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The NIHR provided this funding through the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). The Good Financial Grant Practice (GFGP) is a programme established to strengthen Africa’s research and development infrastructure by developing an innovative standard for the best practices in the management of funds awarded to grantees. The NIHR's funding supported the phase II development of the GFGP standard and associated assessment tools, creating a new and integrated system for the financial governance of grant funds , including international aid, awarded to grantees which will standardise, simplify and strengthen the governance of grant funding.;1) The development of a web-based assessment system to enable pre-award and compliance assessments of grantees to the Good Financial Grant Practice (GFGP) standard. 2) The recruitment of a secretariat at the African Academy of Sciences (AAS) to manage and support the system.;Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-PDP_MMV;Medicines for Malaria Venture;NIHR (ODA);Not Applicable;Research;closed;Medicines for Malaria Venture;Commissioned;£6,100,000.00;2017-12-14;31/06/2018;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The NIHR provided support to the Medicines for Malaria Venture (MMV) to carry out activities relating to the development of new drugs to treat malaria.;"1) Increase investment in chemoprevention; 2) Develop new fast acting molecules to support treatment of uncomplicated and potentially severe malaria; 3) Develop compounds active against laboratory generated resistant strains and field isolates.";Public Private Partnership;Medicines for Malaria Venture (MMV)
GB-GOV-10-AMR_SORT_IT;Structured Operational Research and Training Initiative on building sustainable operational research capacity on antimicrobial resistance in LMICs;NIHR (ODA);Not Applicable;Research;closed;Structured Operational Research and Training Initiative on building sustainable operational research capacity on antimicrobial resistance in LMICs;Commissioned;£8,212,943.00;2018-11-20;31/12/2022;The aim of this programme is to build sustainable operational research capacity to generate and utilize evidence on the emergence, spread and health impact of antimicrobial resistance (AMR), in order to limit this public health problem. The project uses the Structured Operational Research and Training Initiative (SORT IT) and targets a number of low- and middle-income countries, with special focus on Fleming Fund supported countries.;"1. To build adequate and sustainable local Operational Research (OR) capacity on antimicrobial resistance (AMR)
2. To support OR for: a) Improved surveillance and monitoring of the AMR situation in countries. b) Identifying drivers of antimicrobial drug resistance in human populations. c) Improving antimicrobial stewardship and procedural interventions 
3. To build adequate and sustainable structures and processes for evidence-informed decision-making at national level. 
4. To foster mechanisms for knowledge sharing to maximize the potential for broader research impact.";Multilateral;World Health Organization
GB-GOV-10-Wellcome_NIHR_2019;NIHR-Wellcome Global Health Research Partnership;NIHR (ODA);The Wellcome Trust;Research;closed;NIHR Global Health Research Partnership;Commissioned;£29,340,000.00;2019-04-18;31/03/2028;This partnership between the UK’s National Institute for Health Research (NIHR) and Wellcome funds global health researchers who focus on health priorities in low- and middle-income countries.;"The aim of the partnership between DHSC Global Health Research and Wellcome is to support high quality applied global health research in areas of mutual interest, with the following components: 
1. Develop and deliver a portfolio of Fellowships for applicants from low and middle-income countries (LMICs) using the established Wellcome Trust International Fellowship scheme, expanding this to encourage applications in targeted areas where skills shortages have been identified, which align with the priority areas of DHSC global health research and Wellcome and where there is an identified need to build research capability (skills gap). The first areas under discussion are global mental health, non-communicable diseases, snake bite and multimorbidity.
2. Support Major Awards in eligible global health research areas (through Collaborative Awards, Investigator Awards and Senior Research Fellowship schemes) in collaboration with the Wellcome Science Division where NIHR co-funds a small number of joint NIHR-Wellcome awards (50:50) in strategically relevant areas. 
3. Support a policy-uptake initiative with Wellcome Global Health Policy to facilitate global health research uptake into policy and practice.";Academic, Training and Research;The Wellcome Trust
GB-GOV-10-PDP_GARDP_NS;Global Antibiotic Research and Development Partnership’s Neonatal Sepsis Programme (GARDP) support;NIHR (ODA);Not Applicable;Research;active;Global Antimicrobial Research and Development Partnership's Neonatal Sepsis Programme;Commissioned;£4,000,000.00;2020-01-03;31/03/2021;Global Antibiotic Research and Development Partnership’s Neonatal Sepsis Programme (GARDP) support;"The overall purpose of GARDP’s neonatal sepsis programme is to develop up to three new or improved treatments for newborns with severe bacterial infections by 2023. The activities funded under this programme will make an important contribution towards achieving these objectives by prioritising three work packages with the following focus:
1. Improve clinical management of neonatal sepsis
This work package includes three key activities: completion of the global observational study; commencing clinical programme to develop a treatment to be used in place of the current WHO recommended empiric treatment, ampicillin and gentamicin for neonatal sepsis, and conducting clinical and laboratory capability strengthening in support of the clinical programme.
2. Developing new and improved treatments for multi drug-resistant infections in neonates
This work package will aim to develop an effective and safe treatment for confirmed or highly suspected MDR-GN pathogens, including K. pneumoniae, or Acinetobacter spp., that is affordable and adapted for use in neonates.
3. Accelerating regulatory approval and access in high burden LMICs
Through this work package, GARDP will work with WHO, pharmaceutical companies and regulatory authorities to ensure the newly developed treatments are globally accessible and that they are not ‘lost’ to resistance within a few years after their introduction. To achieve this, GARDP, in partnership with the relevant partner(s), will develop regulatory, public health and market access (including supply and distribution) strategies for any treatments developed.";Public Private Partnership;Global Antibiotic Research and Development Partnership
GB-GOV-10-Adol_Health_call4;Research to improve adolescent health in Low and Middle Income Countries: Call 4;NIHR (ODA);Medical Research Council;Research;closed;Research to improve Adolecent Health in Low- and Middle- income (LMIC) country settings:Call 4;Commissioned;£4,250,000.00;2019-12-11;31/03/2028;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. This initiative funds research grants to improve adolescent health in low- and middle-income countries (LMICs).;"This call seeks to provide the research evidence needed to effect real and practical changes to improve adolescent health in low- and middle-income countries (LMICs).
Awards should be genuine interdisciplinary collaborations across social science, biomedical science and other disciplines including health economics and political science. The following thematic area are of particular focus:
-research in conflict-affected and fragile states;
-road traffic and other injuries;
-prevention of interpersonal violence;
-self-harm (including suicide);
-lower respiratory tract infections such as pneumonia;
-prevention and treatment of substance use (alcohol, tobacco and other drugs);
-future Non-Communicable Disease (NCD) risk factors (raised blood pressure, raised blood glucose, obesity and smoking);
-nutrition, diet and physical activity;
-disabilities - mental, intellectual, and physical;
-the transition out of adolescence into adulthood, including the transition to adult services;
-research addressing social (and commercial) determinants of health.";Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-AGHRB_MNH_call1;NIHR-MRC Global Maternal and Neonatal Health Call 1 (2019);NIHR (ODA);Medical Research Council;Research;closed;NIHR-MRC Global Maternal and Neonatal Health;Commissioned;£5,000,000.00;2019-12-11;31/03/2026;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. The purpose of the call is to address the burden of maternal and neonatal mortality and morbidity in low and middle income countries (LMICs), by funding high-quality proposals across the spectrum of basic to applied research;"The first call focuses on the period of pregnancy and birth where the highest risks are faced and where the triple burden of maternal death, neonatal death and stillbirth is heaviest.
Awards support multidisciplinary approaches, build and strengthen research partnerships, and promote capacity building in global maternal and neonatal health research.";Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-DPO;Diagnostics, Prosthetics and Orthotics to Tackle Health Challenges in Developing Countries;NIHR (ODA);Engineering and Physical Sciences Research Council;Research;active;Diagnostics, Prosthetics and Orthotics to Tackle Health Challenges in Developing Countries;Commissioned;£8,000,000.00;2017-12-19;31/03/2021;"The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). This programme is administered by the UK Engineering and Physical Sciences Research Council (EPSRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to EPSRC, which makes onwards disbursements to awardees. This research call is a high quality programme of research centred on innovative healthcare technologies, to tackle the challenges faced by low- and middle-income countries. Proposals must address one of the two priority areas: (1) low cost, rapid, point of care imagine and diagnostic technologies; (2) affordable prosthetics and orthotics.";The overall aim of this call is to develop frugal innovation approaches for healthcare technologies in specific priority areas, which have the potential to revolutionise care pathways in low and middle income countries (LMICs). Such technologies must be developed in partnership with teams from LMICs, and have the delivery of impactful, cost-effective, culturally acceptable, and sustainable welfare and economic benefits within LMICs as their primary objective.;Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-JGHT_1-6;Joint Global Health Trials Initiative: funding for research calls 1-6;NIHR (ODA);"Medical Research Council; The Wellcome Trust; UK Foreign Commonwealth and Development Office";Research;closed;Joint Global Health Trials Initiative;Commissioned;£24,000,000.00;2016-07-12;31/03/2022;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. This activity (Joint Global Health Trials Initiative: funding for research calls 1-6) is a component of Joint Global Health Trials Initiative (GB-GOV-10-JGHT), reported by DHSC.;The objectives of this activity are detailed under Joint Global Health Trials Initiative (GB-GOV-10-JGHT), reported by DHSC.;Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-JGHT_7-11;Joint Global Health Trials Initiative: funding for research calls 7-11;NIHR (ODA);"Medical Research Council; The Wellcome Trust; UK Foreign Commonwealth and Development Office";Research;closed;Joint Global Health Trials Initiative;Commissioned;£26,450,000.00;2017-10-11;31/12/2026;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. This activity (Joint Global Health Trials Initiative: funding for research calls 7-11) is a component of Joint Global Health Trials Initiative (GB-GOV-10-JGHT), reported by DHSC.;The objectives of this activity are detailed under Joint Global Health Trials Initiative (GB-GOV-10-JGHT), reported by DHSC.;Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-PDP_TBA;Global Alliance for TB Drug Development;NIHR (ODA);Not Applicable;Research;closed;Global Alliance for TB Drug Development;Commissioned;£4,500,000.00;2017-12-14;31/06/2018;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The NIHR provided support to the Global Alliance for TB Drug Development to carry out activities relating to the development of new drugs to treat tuberculosis.;"1) Develop and sustain a robust and dynamic research and development (R&D) pipeline for tuberculosis (TB); 2) Strengthen existing research capacity and community engagement; 3) Raise awareness and commitment to TB R&D.";Academic, Training and Research;Global Alliance for TB Drug Development
GB-GOV-10-R2HC_Phase_3;Research for Health in Humanitarian Crises (R2HC) phase III;NIHR (ODA);"UK Foreign Commonwealth and Development Office; The Wellcome Trust";Research;active;Research for Health in Humanitarian Crises (R2HC);Commissioned;£4,000,000.00;2018-08-31;31/03/2021;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The aim of the Research for Health in Humanitarian Crises (R2HC) programme is to develop more effective responses to humanitarian challenges by providing significant funding for high-quality research on the effectiveness of health interventions in humanitarian crises.;1) To strengthen the evidence base around the health challenges associated with humanitarian crises, leading to demonstrated improvements in the effectiveness/efficiency of humanitarian health interventions and programming. 2) Fund research grants that investigate recognised disaster/humanitarian health challenges with collaborative research teams. 3) Produce peer-reviewed publications and products that contribute to informing the evidence base and improving public health humanitarian response. 4) Advance the global public health knowledge-base through practical operational guidance and by improving practice on ethical and methodological approaches to conducting health research programmes in operational humanitarian contexts. 5) Expand and enhance collaborative partnerships between biomedical/public health researchers and the humanitarian sector.;International NGO;Save the Children UK
GB-GOV-10-GACD_Mental_Health;Global Alliance for Chronic Diseases prevention and management of mental disorders call;NIHR (ODA);Medical Research Council;Research;active;Global Alliance for Chronic Diseases (GACD);Commissioned;£1,000,000.00;2018-12-06;31/03/2021;The fourth call for applications under the Global Alliance for Chronic Diseases (GACD) banner focuses on implementation research on child, adolescent and adult age onset mental disorders in low- and middle-income countries, including, but not limited to, dementia, depression, schizophrenia, bipolar disorders, alcohol- and drug-use disorders in low- and middle-income countries. This activity is a component of the Global Alliance for Chronic Diseases programme, GB-GOV-10-GACD.;"Advance prevention strategies and implementation of mental health interventions, alleviating global burden of mental disorders;  Establish the contextual effectiveness of mental health intervention(s), including at health systems level; Improve tailored prevention and treatment; develop affordable management and treatment modalities for mental disorders and expand access to care; Inform health service providers, policy and decision makers on effective scaling up of mental health interventions at local, national and regional levels, including affordability aspects for users and health providers; Reduce health inequalities and inequities, including due consideration of gender and age issues where relevant, in the prevention, treatment and care of mental disorders at both local and global levels; Maximise the use of existing relevant programmes and platforms (e.g. research, data, and delivery platforms); Contribute to the United Nations' Sustainable Development Goals 3, 5, 10 and 17, the Global Action Against Dementia and the First World Health Organization (WHO) Ministerial Conference on Dementia, the WHO Mental Health Action Plan 2013-2020.";Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-EDCTP2_2016WP;European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2016 work plan;NIHR (ODA);Not Applicable;Research;closed;European and Developing Countries Clinical Trials Partnership (EDCTP) phase II;Commissioned;£16,765,635.00;2017-07-11;31/12/2026;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2016 Workplan focussed on, ‘Research and clinical management of patients in PRD epidemics in sub-Saharan Africa Clinical trials’ and ‘Operational research studies to optimise the use of products for poverty-related diseases in mothers, newborns, children and/or adolescents’. This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2).;"1) Support the establishment of a multidisciplinary consortium able to provide accelerated evidence for the optimal clinical management of patients and for guiding the public health response to any severe infectious outbreak caused by pathogens with pandemic potential or that may cause significant damage to health and socio-economics in Africa (including antimicrobial-resistant pathogens); 2) To optimise the use, delivery and access to poverty-related disease medicinal products in sub-Saharan Africa for mothers, newborns, children and/or adolescents. Supported projects should contribute to a better understanding of the role of PRDs in maternal, neonatal, child, and adolescent mortality and morbidity, as well as the barriers for the optimal effectiveness of health products, such as existing drugs or vaccines against these diseases in sub-Saharan Africa.";Public Private Partnership;European and Developing Countries Clinical Trials Partnership (EDCTP)
GB-GOV-10-EDCTP2_2017WP;European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2017 work plan;NIHR (ODA);Not Applicable;Research;closed;European and Developing Countries Clinical Trials Partnership (EDCTP) phase II;Commissioned;£26,500,000.00;2017-07-11;31/12/2026;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty-related diseases as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2017 Workplan focussed on: ‘Strategic Actions Supporting Large-Scale Clinical Trials’ and ‘Clinical Trials to reduce health inequities in pregnant women, newborns and children’. This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2).;"1) support strategic actions (clinical research activities) that are part of a large-scale clinical trial with the potential to achieve rapid advances in the clinical development of new or improved medical interventions (drugs, diagnostics, vaccines, microbicides) for poverty related diseases; 2) accelerate the adaption and/or optimisation of treatment and prevention products (excluding vaccines) for povertyrelated diseases in sub-Saharan Africa for use in pregnant women, newborns and/or children.";Public Private Partnership;European and Developing Countries Clinical Trials Partnership (EDCTP)
GB-GOV-10-RSTMH_SG_2019;Royal Society of Tropical Medicine and Hygiene Small Grants Scheme 2019;NIHR (ODA);Royal Society of Tropical Medicine and Hygiene;Research;active;RSHTM Small Grants;Commissioned;£161,230.26;2019-07-22;30/09/2020;A partnership with the Royal Society of Tropical Medicine and Hygiene (RSTMH) to support small grant awards for early career researchers based in low- and middle-income countries (LMICs). Awards will specifically support research and capacity development for LMIC researchers which will benefit patients and the public in LMICs;"Enable early career researchers and global health professionals in low- and middle-income countries to undertake clinical and applied health research or fieldwork, and access training in grant writing and mentoring; 'pump-prime' funding to early career researchers in strategic research areas; increase the quality and number of applications to other NIHR Global Health Research funded schemes";Government;Royal Society of Tropical Medicine and Hygiene
GB-GOV-10-GCC;Grand Challenges Canada Global Mental Health Programme;NIHR (ODA);Not Applicable;Research;closed;Grand Challenges Canada Global Mental Health Programme;Commissioned;£6,000,000.00;2019-01-10;30/09/2023;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). This Programme is administered by Grand Challenges Canada (GCC). The National Institute for Health Research (NIHR) is contributing in partnership to GCC's Global Mental Health Programme.;The programme aims to seed and transition to scale funding for high impact innovations that improve treatments and/or expand access to care for people living with or are at risk of mental disorders. 75% of all mental disorders start before the age of 24 – the seed call will focus on the mental health needs of young people in low-and middle-income countries.;International NGO;Grand Challenges Canada
GB-GOV-10-GACD_Hyp_Dbt;Global Alliance for Chronic Diseases Scale-up call for the prevention and/or management of hypertension and/or diabetes;NIHR (ODA);Medical Research Council;Research;closed;Global Alliance for Chronic Diseases;Commissioned;£3,154,443.00;2019-12-06;31/03/2028;"The Medical Research Council (MRC) and National Institute for Health Research (NIHR), in partnership with the Global Alliance for Chronic Diseases (GACD), funds implementation research to generate new knowledge on interventions and their implementation for the prevention or management of hypertension and/or diabetes. The Global Alliance for Chronic Diseases Scale-up call for research in the scaling up of evidence-based interventions at the population level for the prevention and/or management of hypertension and/or diabetes (the ""Scale-up call"") will support research associated with the scale-up of interventions for the prevention and/or detection and management of hypertension and/or diabetes in low- and middle-income countries (LMICs).";"To support research associated with the scale-up of interventions for the prevention and/or detection and management of hypertension and/or diabetes in low- and middle-income countries (LMICs); To develop a network of researchers that can enhance the cumulative learning across individual projects and work towards understanding how socio-economic, cultural, geopolitical and policy contexts have influenced results and how findings might be adapted and applied in different settings.";Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-GACD_Membership;Global Alliance for Chronic Diseases Associate Membership contribution;NIHR (ODA);Medical Research Council;Research;active;Global Alliance for Chronic Diseases;Commissioned;£140,000.00;2020-04-24;31/03/2021;The Global Alliance for Chronic Diseases (GACD) funds implementation research to generate new knowledge on interventions and their implementation for the prevention or management of hypertension and/or diabetes. As an Associate Member of the alliance, the Department of Health and Social Care (DHSC) pays an annual fee to support the activities of the GACD.;"1. To tackle the burden of chronic non-communicable diseases (NCDs), by systematically building the evidence base for sound policymaking.
2. Ensure a common understanding of health priorities as well as bigger impact of the collective actions of the Global Alliance for Chronic Diseases (GACD).
3. Joint development and management of funding opportunities and research programmes
4. Coordination of research priorities to avoid the potential duplication of efforts and enable a better focus on research areas where the need for evidence to inform policy, programmes and practice is most urgent.
5. Foster research partnerships to enable knowledge sharing and capacity building";International NGO;GACD Action
GB-GOV-10-GECO;Global Effort on COVID-19 (GECO) Health Research;NIHR (ODA);Global Effort on COVID-19 (GECO);Research;closed;Global Effort on COVID-19 (GECO);Commissioned;£15,000,000.00;2020-02-09;31/12/2022;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The Global Effort on COVID-19 (GECO) Health Research is a cross UK government funding call aiming to support applied health research that will address COVID-19 knowledge gaps in ODA-eligible countries.;The focus is on understanding the pandemic and mitigating its health impacts in low and middle-income country (LMIC) contexts. The call prioritises epidemiology, clinical management, infection control and health system responses, in alignment with the World Health Organisation (WHO) COVID-19 Global Research Roadmap.;Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-BRG_HIV;Biomedical Resources Grant: Harmonisation and Sharing of Linked HIV Cohort Data from Communities and Clinics in Africa;NIHR (ODA);The Wellcome Trust;Research;closed;Biomedical Resources Grant: Harmonisation and Sharing of Linked HIV Cohort Data from Communities and Clinics in Africa;Commissioned;£1,440,688.00;2016-01-12;31/03/2022;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The NIHR is providing support to a grant awarded under the Wellcome Trust's Biomedical Resources programme looking at the harmonisation and sharing of linked HIV cohort data from communities and clinics in Africa.;"1) The new data resource will bridge population-based HIV surveillance in the network for Analysing Longitudinal Population-based HIV data in Africa (ALPHA) and clinical monitoring in the network for International Epidemiologic Databases to Evaluate AIDS (IeDEA), ensuring that data on people who participate in both ALPHA and IeDEA cohorts is exchangable and shared across the two networks. HIV clinics serving ALPHA sites but not currently part of IeDEA will be supported to attain data management standards required for IeDEA membership, using the international standard HIV Cohort Data Exchange Protocol (HICDEP) to ensure global data comparability. 2) The resource will provide robust, population-based data for all stages of the HIV care continuum from infection to viral suppression, enabling empirical monitoring of all three UNAIDS 90-90-90 goals, which neither network can do independently. It will automate and document the creation of standardised analytical datasets, extending the Centre-in-a-box methodology pioneered by the INDEPTH network. Data integration software will build and document transformations for compiling each site’s data into harmonised formats required for pooled datasets. Key summary statistical updates will be disseminated regularly through ALPHA web pages. Pooled datasets will be archived in the INDEPTH ""iShare"" public repository using the Data Documentation Initiative standard.";Academic, Training and Research;The Wellcome Trust
GB-GOV-10-PDP_FIND;Foundation for Innovative New Diagnostics;NIHR (ODA);Not Applicable;Research;active;Foundation for Innovative New Diagnostics;Commissioned;£1,174,200.00;2018-03-23;01/07/2018;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The NIHR provided support to the Foundation for Innovative New Diagnostics (FIND) for the development of critical diagnostic assays for prioritised Target Product Profiles (TPPs) using innovative technology platforms and business models.;Develop critical diagnostic assays for prioritised Target Product Profiles (TPPs) using innovative technology platforms and business models.;Public Private Partnership;Foundation for Innovative New Diagnostics (FIND)
GB-GOV-10-Adol_Health_call2;Research to Improve Adolescent Health in Low- and Middle-Income Country (LMIC) Settings: call 2;NIHR (ODA);Medical Research Council;Research;closed;Applied Research for Adolescent Health in Low and Middle Income Countries;Commissioned;£6,000,000.00;2018-12-06;31/10/2022;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. This activity is a component of the Applied Research for Adolescent Health in Low and Middle Income Countries  programme (GB-GOV-10-Adol_Health). This initiative funds research grants to improve adolescent health in low- and middle-income countries (LMICs).;"1 ) Fund high-quality research to address major health issues that emerge at the adolescent phase of life; 2) Provide the research evidence needed to effect real and practical changes to improve adolescent health in Low- and Middle-Income Countries (LMICs); 3) Encourage genuine interdisciplinary collaborations across social science, biomedical science and other disciplines including health economics and political science; 4) Support capacity building in research; 5) Encourage equitable partnerships with, and scientific leadership from, LMIC investigators.";Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-GRSF;Global Road Safety Facility (GRSF);NIHR (ODA);UK Foreign Commonwealth and Development Office;Research;closed;Global Road Safety Facility (GRSF);Commissioned;£5,300,000.00;2018-05-10;31/12/2023;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The World Bank’s Global Road Safety Facility aims to address the growing public health crisis of road traffic deaths and injuries in low- and middle-income countries (LMICs) through supporting the scale-up of scientific, technological and managerial capacities to effectively manage road safety.;1) Fund applied research grants under the UN’s five pillars for road safety: Road Safety Management, Safer Roads and Mobility, Safer Vehicles, Safer Road Users, Post-Crash Response. 2) Improve global road safety data collection 3) Increase knowledge and evidence base to support policy interventions;Multilateral;International Bank for Reconstruction and Development
GB-GOV-10-EDCTP2_2018WP;European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2018 work plan;NIHR (ODA);Not Applicable;Research;closed;European and Developing Countries Clinical Trials Partnership (EDCTP) phase II;Commissioned;£31,742,000.00;2017-07-11;31/12/2026;"The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2018 Workplan focussed on: ‘Advances in product development for effective prevention, treatment and management of co-infections and co-morbidities’; ‘Diagnostic tools for poverty-related diseases Challenge’; and ""Vaccines for diarrhoeal diseases or lower respiratory tract infections"". This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2).";"1) Support actions that lead to improvements in  the prevention, treatment and/or clinical management of co-infections and co-morbidities in sub-Saharan Africa; 2) provide funding to projects focusing on validation of clinical performance and/or implementation of new or improved diagnostic tools and technologies for the detection of any of the PRDs including co-infections 3) improve the performance of diagnosis, prediction, monitoring, intervention or assessment of therapeutic response, with a significant impact on clinical decision and health outcomes 4) contribute towards the reduction of the burden of diarrhoeal diseases or lower respiratory tract infections in sub-Saharan Africa and lead to the advancement of vaccine candidates along the product development pipeline.";Public Private Partnership;European and Developing Countries Clinical Trials Partnership (EDCTP)
GB-GOV-10-EDCTP2_PM;European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for programme management activities;NIHR (ODA);Not Applicable;Research;closed;European and Developing Countries Clinical Trials Partnership (EDCTP) phase II;Commissioned;£925,500.00;2017-07-11;31/12/2026;The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials. The NIHR provided a funding contribution to EDCTP 2 programme management activities. This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2).;Support the European & Developing Countries Clinical Trials Partnership to effectively deliver EDCTP2 programmes.;Public Private Partnership;European and Developing Countries Clinical Trials Partnership (EDCTP)
GB-GOV-10-GPSC;Global Patient Safety Collaborative;NIHR (ODA);Not Applicable;Research;active;Global Patient Safety Collaborative;Commissioned;£1,500,075.00;2018-03-09;31/03/2021;The main objective of the Global Patient Safety Collaborative (GPSC) is to secure and scale up global action on patient safety as well as to work in close collaboration with selected low- and middle-income countries (LMICs) in their quest to reduce the risk of avoidable harm and improve the safety of their national health care systems.;"1) Strengthen leadership to promote patient safety across all sectors and settings; 2) Develop a competent workforce through education and training in patient safety; and 3) Support research capacities and evidence-based policies, strategies and standards.";Government;World Health Organization
GB-GOV-10-RSTMH_SG_2020;Royal Society of Tropical Medicine and Hygiene Small Grants Scheme 2020;NIHR (ODA);Royal Society of Tropical Medicine and Hygiene;Research;active;RSHTM Small Grants;Commissioned;£590,041.00;2020-05-28;31/01/2022;A partnership with the Royal Society of Tropical Medicine and Hygiene (RSTMH) to support small grant awards for early career researchers based in low- and middle-income countries (LMICs). Awards will specifically support research and capacity development for LMIC researchers which will benefit patients and the public in LMICs;"Enable early career researchers and global health professionals in low- and middle-income countries to undertake clinical and applied health research or fieldwork, and access training in grant writing and mentoring; 'pump-prime' funding to early career researchers in strategic research areas; increase the quality and number of applications to other NIHR Global Health Research funded schemes";Other Public Sector;Royal Society of Tropical Medicine and Hygiene
GB-GOV-10-Adol_Health_call3;Research to Improve Adolescent Health in Low- and Middle-Income Country (LMIC) Settings: call 3;NIHR (ODA);Medical Research Council;Research;closed;Research to improve Adolecent Health in Low- and Middle- income (LMIC) country settings:Call 3;Commissioned;£2,003,780.00;2019-02-05;31/03/2028;This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. This initiative funds research grants to improve adolescent health in low- and middle-income countries (LMICs).;"Overall this call will support high-quality, applied research answering questions of effectiveness and access that will result in improved adolescent health in LMICs. Sub-objectives include:
1 ) Fund high-quality research to address major health issues that emerge at the adolescent phase of life;
2) Provide the research evidence needed to effect real and practical changes to improve adolescent health in Low- and Middle-Income Countries (LMICs);
3) Encourage genuine interdisciplinary collaborations across social science, biomedical science and other disciplines including health economics and political science;
4) Support capacity building in research";Government;UK - Department for Business, Energy and Industrial Strategy
GB-GOV-10-ECTIMH;Sponsorship for the 11th European Congress on Tropical Medicine and International Health;NIHR (ODA);Not Applicable;Research;active;RSHTM Small Grants;Commissioned;£10,000.00;2019-08-21;15/11/2019;NIHR provided sponsorship to the Royal Society of Tropical Medicine and Hygiene to support two panel members from low and middle income countries to attend the 11th European Congress on Tropical Medicine and International Health;To support a joint panel session on multimorbidity, including providing travel sponsorships for low and middle income country attendees to participate in the conference;Other Public Sector;Royal Society of Tropical Medicine and Hygiene
GB-GOV-10-Wellcome_UKCDR;UK Collaborative on Development Research (UCKDR) annual contribution;NIHR (ODA);"The Wellcome Trust; UK Foreign Commonwealth and Development Office; UK Research and Innovation; UK Department for Business, Energy and Industrial Strategy; UK Department for Environment, Food and Rural Affairs";Research;closed;UK Collaborative on Development Research (UCKDR);Commissioned;£444,000.00;2019-07-29;31/03/2022;The Department of Health and Social Care (DHSC) provides a funding contribution to the UK Collaborative on Development Research (UKCDR), a neutral and impartial entity governed by the Strategic Coherence of ODA-funded Research (SCOR) Board. UKCDR provide high-level coherence for UK Official Development Assistance (ODA) research.;"UKCDR have a principal commitment to data mapping, analysis and foresight, with remaining activities built upon this strong foundation of knowledge and evidence. UKCDR have four integrated and overlapping aims:
-Mapping, analysis and foresight
-Convening for collaboration and joint action
-Sharing information, learning and best practice
-A collective voice to shape policy";Academic, Training and Research;The Wellcome Trust
GB-GOV-10-EDCTP2_2020WP;European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2020 workplan;NIHR (ODA);Not Applicable;Research;closed;European and Developing Counteries Clinical Trials Partnership;Commissioned;£3,800,000.00;2020-08-28;31/12/2026;"The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2020 Workplan focussed on: ‘Mobilisation of funding for COVID-19 research in sub-Saharan Africa’; ‘Addressing gender and diversity gaps in clinical research capacity at the EDCTP Regional Networks of Excellence; and ""Capacity development for disease outbreak and epidemic response in sub-Saharan Africa, in collaboration with Africa Centres for Disease Control and Prevention (Africa CDC)"". This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2).";"The activities of the EDCTP2 programme will contribute towards achieving the following five specific objectives: Increase the number of new or improved medical interventions for poverty-related diseases (PRDs), including neglected ones; Strengthen cooperation with sub-Saharan African countries, in particular on building their capacity for conducting clinical trials in compliance with fundamental ethical principles and relevant national, EU and international legislation; Better coordinate, align and, where appropriate, integrate relevant national programmes to increase the cost-effectiveness of European public investments; Extend international cooperation with other public and private partners to ensure that the impact of all research is maximised and that synergies can be taken into consideration and to achieve leveraging of resources and investments; Increase impact due to effective cooperation with relevant EU initiatives, including its development assistance.";Public Private Partnership;European and Developing Countries Clinical Trials Partnership (EDCTP)
